prostate cancer and prostatic diseases سال:2016 - دوره:19

Fa | Ar | En


prostate cancer and prostatic diseases
سال:2016 - دوره:19 - شماره:4

A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment - صفحه:390-394 A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients - صفحه:333-339 A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients - صفحه:323-332 Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis - صفحه:358-366 Can nomograms improve our ability to select candidates for active surveillance for prostate cancer? - صفحه:385-389 Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients - صفحه:374-379 Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer? - صفحه:380-384 Erratum: A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients - صفحه:429-429 Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis - صفحه:417-422 Increasing incidence of metastatic prostate cancer in the United States (2004–2013) - صفحه:395-397 Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort - صفحه:423-428 Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance database - صفحه:406-411 Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancer - صفحه:398-405 Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells - صفحه:349-357 Robots drive the German radical prostatectomy market: a total population analysis from 2006 to 2013 - صفحه:412-416 The very-high-risk prostate cancer: a contemporary update - صفحه:340-348 Tumor features and survival after radical prostatectomy among antidiabetic drug users - صفحه:367-373